Application Notes & Case Studies

  1. Container Closure Integrity Test Method Development For Autoinjectors 8/6/2025

    Discover an autoinjector technology that leverages laser-based headspace analysis for container closure integrity to advance biologic drug delivery with precision, safety, and regulatory confidence.

  2. Increasing Batch Size And Reducing Cycle Times For A Biologic 8/5/2025

    JHS partnered with a global pharma company to optimize biologic production, increasing output by 50% and reducing batch release times by up to 30%.

  3. AI Predictive Maintenance Prevents Batch Loss And Production Shutdown 8/5/2025

    AI-powered predictive maintenance with wireless vibration sensors prevented costly batch loss and production shutdowns in pharma manufacturing by detecting and fixing equipment issues before failures occurred.

  4. Simplifying Antibody-Drug Conjugate Payload Synthesis 8/5/2025

    ADC's offer precise, targeted therapy by delivering cytotoxic agents directly to diseased cells. Learn how this method minimizes harm to healthy tissue and revolutionizes treatment for cancer.

  5. Balancing Protein A Resin Cost, Performance, And Productivity 7/31/2025

    Optimizing input parameters like DBC, flow rate, and resin durability is key to boosting productivity in downstream bioprocessing. Discover how to tailor resin choices to meet your specific process requirements.

  6. Complementing Routine Peptide Monitoring 7/29/2025

    Discover how to enhance your peptide analysis by integrating UV and mass spectral data into a single, streamlined workflow to boost data confidence and lab efficiency.

  7. LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting 7/29/2025

    Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.

  8. Characterization And Impurity Profiling Of Combined Amylin And GLP-1 Analogs 7/29/2025

    GLP-1 receptor agonists are transforming diabetes and weight loss treatment. Discover how to enable precise impurity analysis and characterization of complex, fatty acid-modified peptide therapeutics.

  9. Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS 7/29/2025

    Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.

  10. Development Of A High Sensitivity SPE-LC-MS/MS Assay 7/29/2025

    Achieve ultra-sensitive glucagon quantification with ionKey/MS, μElution SPE, and advanced MS fragmentation to deliver low LOD, reduced sample loss, and enhanced confidence in results.